drugset / Trial / NCT04968392

Single-shot Adductor Canal Block With Levobupivacaine and Dexmedetomidine in Total Knee Arthroplasty

NCT04968392

Phase 2/3 Completed 60 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

Total knee arthroplasty surgery is associated with severe postoperative pain and adequate pain management is necessary for early postoperative mobilization and rehabilitation. Although good postoperative pain control may be achieved by continuous epidural anesthesia or femoral nerve block, both methods have adverse effects such as muscle weakness, which may delay postoperative mobilization.

Timeline

Start
2019-03-01
Primary completion
2020-02-01
Completion
2020-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg
Background Levobupivacaine Other / unclassified 0.25 %

Indications

No indication recorded.